Table 3.

DEX implantation in patients with glaucoma or cataracts.

	Spanish Consensus 2019	French Consensus	Asian Consensus	Emirates Society of Ophthalmology Consensus	Italian Consensus	Saudi Arabia Consensus
DEX implant in glaucoma patients	Not considered	Patient with stable glaucoma.	Patients with stable glaucoma treated with monotherapy can undergo DEX implant.	DEX implant should not be used in patients with advanced glaucoma requiring more than three medications.	Consensus not reached regarding the use of DEX implant in patients with ocular hypertension controlled via topical therapy.	Not considered
IOP monitoring	Not considered	Monitoring IOP between the first and second month after DEX implant.	Routine IOP check at 6 weeks post-DEX implant; in glaucoma patients at week 1, week 2, and 4 to 6 weeks post-treatment.	Not considered	Not considered	Not considered
Topical steroid loading test utility	Not considered	Not needed	Not considered	Not considered	Not useful	Not considered
DEX implant and cataract development	Not considered	Low risk to develop cataracts after 2 injections.	DEX implant also in phakic patient if it is supposed to be the most effective treatment in that patient.	Not considered	Not considered	Not considered
DME and cataract surgery	Not considered	DEX implant 2 weeks before cataract extraction.	Not considered	Not considered	Not considered	Not considered